{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:17:28Z","timestamp":1792783048063,"version":"4.5.0"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma Tor Vergata","id":[{"id":"https:\/\/ror.org\/02p77k626","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Crohn\u2019s disease (CD) is a long-lasting, recurring inflammatory bowel disease (IBD) marked by segmental, transmural inflammation that may affect any part of the gastrointestinal tract. Growing evidence suggests that CD does not originate from a single pathogenic mechanism, but instead results from the convergence of various biological disturbances that collectively disrupt intestinal homeostasis. Genetic alterations that weaken microbial detection, autophagy, and epithelial protection appear to establish initial vulnerabilities, enabling microbes to trigger exaggerated immune responses. This vulnerability is further exacerbated by environmental factors that intensify host microbial imbalance. The ensuing microenvironment fosters a significant production of effector molecules, which exacerbate the existing inflammation and activate stromal cells, which in turn drive tissue remodeling and structural complications such as ulceration, strictures, and fistulas. In this article, we synthesize the knowledge on the molecular and cellular mechanisms involved in CD pathogenesis, emphasizing the dynamic interplay between immune and stromal components that contributes to a disease-permissive environment. We also examine key inflammatory pathways and signaling networks involved in disease progression and discuss how these mechanistic insights inform existing and emerging therapeutic strategies.<\/jats:p>","DOI":"10.1007\/s10753-026-02561-z","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T07:34:51Z","timestamp":1783755291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Crohn\u2019s Disease: From Immune Dysregulation to Intestinal Damage"],"prefix":"10.1007","volume":"49","author":[{"given":"Silvia","family":"Salvatori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachele","family":"Frascatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"De Vico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Marafini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Monteleone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"2561_CR1","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","volume":"403","author":"M Dolinger","year":"2024","unstructured":"Dolinger, M., J. Torres, and S. Vermeire. 2024. Crohn\u2019s Disease. Lancet 403:1177\u20131191. https:\/\/doi.org\/10.1016\/S0140-6736(23)02586-2","journal-title":"Lancet"},{"key":"2561_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu13030886","volume":"13","author":"SP Wiertsema","year":"2021","unstructured":"Wiertsema, S. P., J. van Bergenhenegouwen, J. Garssen, and L. M. J. Knippels. 2021. The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies. Nutrients 13:1\u201314. https:\/\/doi.org\/10.3390\/nu13030886","journal-title":"Nutrients"},{"key":"2561_CR3","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1080\/00365521.2017.1349173","volume":"52","author":"B Ahluwalia","year":"2017","unstructured":"Ahluwalia, B., M. K. Magnusson, and L. \u00d6hman. 2017. Mucosal Immune System of the Gastrointestinal Tract: Maintaining Balance between the Good and the Bad. Scandinavian Journal Of Gastroenterology 52:1185\u20131193. https:\/\/doi.org\/10.1080\/00365521.2017.1349173","journal-title":"Scandinavian Journal Of Gastroenterology"},{"key":"2561_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582.Host-microbe","volume":"491","author":"L Jostins","year":"2012","unstructured":"Jostins, L., S. Ripke, R. K. Weersma, R. H. Duerr, D. P. McGovern, K. Y. Hui, J. C. Lee, L. P. Schumm, Y. Sharma, C. A. Anderson, J. Essers, M. Mitrovic, K. Ning, I. Cleynen, E. Theatre, S. L. Spain, S. Raychaudhuri, P. Goyette, Z. Wei, C. Abraham, J. P. Achkar, T. Ahmad, L. Amininejad, and C. J. Ananthakr. 2012. Host-Microbe Interactions Have Shaped the Genetic Architecture of Inflammatory Bowel Disease. Nature 491:119\u2013124. https:\/\/doi.org\/10.1038\/nature11582.Host-microbe","journal-title":"Nature"},{"key":"2561_CR5","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/ecco-jcc\/jjab048","volume":"15","author":"J Torres","year":"2021","unstructured":"Torres, J., J. Halfvarson, I. Rodr\u00edguez-Lago, C. R. H. Hedin, T. Jess, M. Dubinsky, K. Croitoru, and J. F. Colombel. 2021. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Prediction and Prevention of Inflammatory Bowel Disease. J Crohn\u2019s Colitis 15:1443\u20131454. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab048","journal-title":"J Crohn\u2019s Colitis"},{"key":"2561_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura, Y., D. K. Bonen, N. Inohara, D. L. Nicolae, F. F. Chen, R. Ramos, H. Britton, T. Moran, R. Karaliuskas, and R. H. Duerr et al. 2001. A Frameshift Mutation in NOD2 Associated with Susceptibility to Crohn\u2019s Disease. Nature 411:603\u2013606. https:\/\/doi.org\/10.1038\/35079114","journal-title":"Nature"},{"key":"2561_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"JP Hugot","year":"2001","unstructured":"Hugot, J. P., M. Chamaillard, H. Zouali, S. Lesage, J. P. C\u00e9zard, J. Belaiche, S. Almer, C. Tysk, C. A. O\u2019morain, and M. Gassull et al. 2001. Association of NOD2 Leucine-Rich Repeat Variants with Susceptibility to Crohn\u2019s Disease. Nature 411:599\u2013603. https:\/\/doi.org\/10.1038\/35079107","journal-title":"Nature"},{"key":"2561_CR8","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1136\/gut.52.11.1591","volume":"52","author":"Y Ogura","year":"2003","unstructured":"Ogura, Y., S. Lala, W. Xin, E. Smith, T. A. Dowds, F. F. Chen, E. Zimmermann, M. Tretiakova, J. H. Cho, and J. Hart et al. 2003. Expression of NOD2 in Paneth Cells: A Possible Link to Crohn\u2019s Ileitis. Gut 52:1591\u20131597. https:\/\/doi.org\/10.1136\/gut.52.11.1591","journal-title":"Gut"},{"key":"2561_CR9","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1136\/gut.52.11.1533","volume":"52","author":"MC Aldhous","year":"2003","unstructured":"Aldhous, M. C., E. R. Nimmo, and J. Satsangi. 2003. NOD2\/CARD15 and the Paneth Cell: Another Piece in the Genetic Jigsaw of Inflammatory Bowel Disease. Gut 52:1533\u20131535. https:\/\/doi.org\/10.1136\/gut.52.11.1533","journal-title":"Gut"},{"key":"2561_CR10","doi-asserted-by":"publisher","first-page":"14739","DOI":"10.1073\/pnas.1003363107","volume":"107","author":"A Biswas","year":"2010","unstructured":"Biswas, A., Y. J. Liu, L. Hao, A. Mizoguchi, N. H. Salzman, C. L. Bevins, and K. S. Kobayashi. 2010. Induction and Rescue of Nod2-Dependent Th1-Driven Granulomatous Inflammation of the Ileum. Proc. Natl. Acad. Sci. U. S. A. 107:14739\u201314744. https:\/\/doi.org\/10.1073\/pnas.1003363107","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"2561_CR11","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/ni1092","volume":"5","author":"T Watanabe","year":"2004","unstructured":"Watanabe, T., A. Kitani, and P. J. Murray. 2004. NOD2 Is a Negative Regulator of Toll-like Receptor 2-Mediated T Helper Type 1 Responses. Nature Immunology 5(8):800\u2013808. https:\/\/doi.org\/10.1038\/ni1092","journal-title":"Nature Immunology"},{"key":"2561_CR12","doi-asserted-by":"publisher","unstructured":"Huang, H., Fang, M., Jostins, L., Umi\u0107evi\u0107 Mirkov, M., Boucher, G., Anderson, C. A., Andersen, V., Cleynen, I., Cortes, A., Crins, F., D'Amato, M., Deffontaine, V., Dmitrieva, J., Docampo, E., Elansary, M., Farh, K. K., Franke, A., Gori, A. S., Goyette, P., Halfvarson, J., Haritunians, T., Knight, J., Lawrance, I. C., Lees, C. W., Louis, E., Mariman, R., Meuwissen, T., Mni, M., Momozawa, Y., Parkes, M., Spain, S. L., Th\u00e9\u00e2tre, E., Trynka, G., Satsangi, J., van Sommeren, S., Vermeire, S., Xavier, R. J., Weersma, R. K., Duerr, R. H., Mathew, C. G., Rioux, J. D., McGovern, D. P. B., Cho, J. H., Georges, M., Daly, M. J., and J. C. Barrett. 2017. Fine-mapping inflammatory bowel disease Loci to single-variant resolution. Nature 547:173\u2013178. https:\/\/doi.org\/10.1038\/nature22969.","DOI":"10.1038\/nature22969"},{"key":"2561_CR13","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/01.MIB.0000172808.03877.4d","volume":"11","author":"C Becker","year":"2005","unstructured":"Becker, C., S. Wirtz, and M. F. Neurath. 2005. Stepwise Regulation of TH1 Responses in Autoimmunity: IL-12-Related Cytokines and Their Receptors. Inflammatory Bowel Diseases 11:755\u2013764. https:\/\/doi.org\/10.1097\/01.MIB.0000172808.03877.4d","journal-title":"Inflammatory Bowel Diseases"},{"key":"2561_CR14","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.chom.2023.08.002","volume":"31","author":"KK Jang","year":"2023","unstructured":"Jang, K. K., T. Heaney, M. London, Y. Ding, G. Putzel, D. Ercelen, Y. Chen, J. Axelrad, S. Gurunathan, and C. Zhou et al. 2023. Antimicrobial overproduction sustains intestinal inflammation by inhibiting Enterococcus colonization. Cell Host & Microbe 31:1450\u20131468. https:\/\/doi.org\/10.1016\/j.chom.2023.08.002","journal-title":"Cell Host & Microbe"},{"key":"2561_CR15","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1053\/j.gastro.2010.07.006","volume":"139","author":"CR Homer","year":"2010","unstructured":"Homer, C. R., A. L. Richmond, N. A. Rebert, J. Achkar, and C. McDonald. 2010. ATG16L1 and NOD2 Interact in an Autophagy-Dependent Antibacterial Pathway Implicated in Crohn\u2019s Disease Pathogenesis. Gastroenterology 139:1630\u20131641. https:\/\/doi.org\/10.1053\/j.gastro.2010.07.006","journal-title":"Gastroenterology"},{"key":"2561_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/ueg2.12477","volume":"12","author":"I Simovic","year":"2024","unstructured":"Simovic, I., I. Hilmi, R. T. Ng, K. S. Chew, S. Y. Wong, W. S. Lee, S. Riordan, and N. Casta\u00f1o-Rodr\u00edguez. 2024. ATG16L1 Rs2241880\/T300A Increases Susceptibility to Perianal Crohn\u2019s Disease: An Updated Meta-Analysis on Inflammatory Bowel Disease Risk and Clinical Outcomes. United Eur Gastroenterol J 12:103\u2013121. https:\/\/doi.org\/10.1002\/ueg2.12477","journal-title":"United Eur Gastroenterol J"},{"key":"2561_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ni.1823","volume":"11","author":"LH Travassos","year":"2010","unstructured":"Travassos, L. H., L. A. M. Carneiro, M. Ramjeet, S. Hussey, Y. G. Kim, J. G. Magalhes, L. Yuan, F. Soares, E. Chea, and L. Le Bourhis et al. 2010. Nod1 and Nod2 Direct Autophagy by Recruiting ATG16L1 to the Plasma Membrane at the Site of Bacterial Entry. Nature Immunology 11:55\u201362. https:\/\/doi.org\/10.1038\/ni.1823","journal-title":"Nature Immunology"},{"key":"2561_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1462-5822.2009.01381.x.Crohn","volume":"12","author":"Anne-Lise Pierre Lapaquette","year":"2010","unstructured":"Pierre Lapaquette, Anne-Lise, Alan Glasser, Ramnik J. Huett, and Xavier. 2010. Crohn\u2019s Disease-Associated Adherent-Invasive E. Coli Are Selectively Favoured by Impaired Autophagy to Replicate Intracellularly. Cellular Microbiology 12:99\u2013113. https:\/\/doi.org\/10.1111\/j.1462-5822.2009.01381.x.Crohn","journal-title":"Cellular Microbiology"},{"key":"2561_CR19","first-page":"623","volume":"3","author":"HF Ghazi","year":"2015","unstructured":"Ghazi, H. F., N. A. Mohammed, and R. J. Hussein. 2015. Detection of Norovirus in Association with ATG16L1 T300A Genetic Variant in Crohn\u2019s. International Journal of Advanced Research 3:623\u2013628.","journal-title":"International Journal of Advanced Research"},{"key":"2561_CR20","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1084\/jem.20170558","volume":"214","author":"Y Matsuzawa-Ishimoto","year":"2017","unstructured":"Matsuzawa-Ishimoto, Y., Y. Shono, L. E. Gomez, V. M. Hubbard-Lucey, M. Cammer, J. Neil, M. Z. Dewan, S. R. Lieberman, A. Lazrak, and J. M. Marinis et al. 2017. Autophagy Protein ATG16L1 Prevents Necroptosis in the Intestinal Epithelium. Journal Of Experimental Medicine 214:3687\u20133705. https:\/\/doi.org\/10.1084\/jem.20170558","journal-title":"Journal Of Experimental Medicine"},{"key":"2561_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.molcel.2018.11.018","volume":"73","author":"S Mehto","year":"2019","unstructured":"Mehto, S., K. K. Jena, P. Nath, S. Chauhan, S. P. Kolapalli, S. K. Das, P. K. Sahoo, A. Jain, G. A. Taylor, and S. Chauhan. 2019. The Crohn\u2019s Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by Impeding Its Assembly and by Mediating Its Selective Autophagy. Molecular Cell 73:429\u2013445e7. https:\/\/doi.org\/10.1016\/j.molcel.2018.11.018","journal-title":"Molecular Cell"},{"key":"2561_CR22","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1093\/hmg\/ddi379","volume":"14","author":"K Yamazaki","year":"2005","unstructured":"Yamazaki, K., D. McGovern, J. Ragoussis, M. Paolucci, H. Butler, D. Jewell, L. Cardon, M. Takazoe, T. Tanaka, and T. Ichimori et al. 2005. Single Nucleotide Polymorphisms in TNFSF15 Confer Susceptibility to Crohn\u2019s Disease. Human Molecular Genetics 14:3499\u20133506. https:\/\/doi.org\/10.1093\/hmg\/ddi379","journal-title":"Human Molecular Genetics"},{"key":"2561_CR23","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.crohns.2014.04.002","volume":"8","author":"DH Yang","year":"2014","unstructured":"Yang, D. H., S. K. Yang, K. Song, M. Hong, S. H. Park, H. S. Lee, J. B. Kim, H. J. Lee, S. K. Park, and K. W. Jung et al. 2014. TNFSF15 Is an Independent Predictor for the Development of Crohn\u2019s Disease-Related Complications in Koreans. J Crohn\u2019s Colitis 8:1315\u20131326. https:\/\/doi.org\/10.1016\/j.crohns.2014.04.002","journal-title":"J Crohn\u2019s Colitis"},{"issue":"9","key":"2561_CR24","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1053\/j.gastro.2019.03.013","volume":"54","author":"ChristineR Aleksejs Sazonovs","year":"2022","unstructured":"Aleksejs Sazonovs, Christine R., R. Stevens, K. Guhan, B. Venkataraman, T. Avila, Tariq Maria, Matthieu Abreu, A. N. A. Ahmad, Allez, Gil, and Atzmon et al. 2022. Large-Scale Sequencing Identifies Multiple Genes and Rare Variants Associated with Crohn\u2019s Disease Susceptibility. Nature Genetics 54(9):1275\u20131283. https:\/\/doi.org\/10.1053\/j.gastro.2019.03.013","journal-title":"Nature Genetics"},{"key":"2561_CR25","doi-asserted-by":"publisher","unstructured":"Liu, Z., R. Liu, H. Gao, S. Jung, X. Gao, R. Sun, X. Liu, Y. Kim, H. Lee, and Y. Kawai et al. 2023. Systematic Review with Meta-Analysis: Breastfeeding and the Risk of Crohn\u2019s Disease and Ulcerative Colitis. 55:796\u2013806. https:\/\/doi.org\/10.1038\/s41588-023-01384-0","DOI":"10.1038\/s41588-023-01384-0"},{"key":"2561_CR26","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ng.3359","volume":"47","author":"JZ Liu","year":"2016","unstructured":"Liu, J. Z., and S. Sommeren. 2016. Association Analyses Identify 38 Susceptibility Loci for Inflammatory Bowel Disease and Highlight Shared Genetic Risk across Populations. Nature Genetics 47:979\u2013986. https:\/\/doi.org\/10.1038\/ng.3359. HuangH.Ng, S.C.; Alberts, R.","journal-title":"Nature Genetics"},{"key":"2561_CR27","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/aogs.14427","volume":"101","author":"C Hellsing","year":"2022","unstructured":"Hellsing, C., A. K. \u00d6rtqvist, E. Hagel, C. Mesas-Burgos, U. O. Gustafsson, and A. L. Granstr\u00f6m. 2022. Delivery Mode and Risk of Gastrointestinal Disease in the Offspring. Acta Obstetricia Et Gynecologica Scandinavica 101:1146\u20131152. https:\/\/doi.org\/10.1111\/aogs.14427","journal-title":"Acta Obstetricia Et Gynecologica Scandinavica"},{"key":"2561_CR28","first-page":"393","volume":"9","author":"CN Bernstein","year":"2013","unstructured":"Bernstein, C. N. 2013. Antibiotic Use and the Risk of Crohn\u2019s Disease. Gastroenterologia Y Hepatologia 9:393\u2013395.","journal-title":"Gastroenterologia Y Hepatologia"},{"key":"2561_CR29","doi-asserted-by":"publisher","unstructured":"Inchingolo, F., Inchingolo, A. D., Palumbo, I., Trilli, I., Guglielmo, M., Mancini, A., Palermo, A., Inchingolo, A. M., and G. Dipalma. 2024. The impact of cesarean section delivery on intestinal microbiota: Mechanisms, consequences, and perspectives\u2014A systematic review. International Journal of Molecular Sciences 25:1055. https:\/\/doi.org\/10.3390\/ijms25021055.","DOI":"10.3390\/ijms25021055"},{"key":"2561_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics11040470","volume":"11","author":"Y Kwon","year":"2022","unstructured":"Kwon, Y., Y. S. Cho, Y. M. Lee, S. J. Kim, J. Bae, and S. J. Jeong. 2022. Changes to Gut Microbiota Following Systemic Antibiotic Administration in Infants. Antibiotics 11:1\u201312. https:\/\/doi.org\/10.3390\/antibiotics11040470","journal-title":"Antibiotics"},{"key":"2561_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/ecco-jcc\/jjw139","volume":"11","author":"Irene Ivan Monteleone","year":"2016","unstructured":"Ivan Monteleone, Irene, Vincenzo Marafini, Davide Di Dinallo, Edoardo Fusco, Francesca Troncone, and F. L. Zorzi. 2016. Sodium Chloride-Enriched Diet Enhances Inflammatory Cytokine Production and Exacerbates Experimental Colitis in Mice. J Crohn\u2019s Colitis 11:237\u2013245.","journal-title":"J Crohn\u2019s Colitis"},{"key":"2561_CR32","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1136\/gutjnl-2013-305304","volume":"63","author":"AN Ananthakrishnan","year":"2014","unstructured":"Ananthakrishnan, A. N., H. Khalili, G. G. Konijeti, L. M. Higuchi, P. De Silva, C. S. Fuchs, W. C. Willett, J. M. Richter, and A. T. Chan. 2014. Long-Term Intake of Dietary Fat and Risk of Ulcerative Colitis and Crohn\u2019s Disease. Gut 63:776\u2013784. https:\/\/doi.org\/10.1136\/gutjnl-2013-305304","journal-title":"Gut"},{"key":"2561_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-48749-2","volume":"9","author":"M Laffin","year":"2019","unstructured":"Laffin, M., R. Fedorak, A. Zalasky, H. Park, A. Gill, A. Agrawal, A. Keshteli, N. Hotte, and K. L. Madsen. 2019. A High-Sugar Diet Rapidly Enhances Susceptibility to Colitis via Depletion of Luminal Short-Chain Fatty Acids in Mice. Scientific Reports 9:1\u201311. https:\/\/doi.org\/10.1038\/s41598-019-48749-2","journal-title":"Scientific Reports"},{"issue":"17","key":"2561_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/nu14173627","volume":"14","author":"GL Trakman","year":"2022","unstructured":"Trakman, G. L., W. Y. Y. Lin, A. L. Hamilton, A. L. W. Brien, A. Stanley, J. Y. Ching, J. Yu, J. W. Y. Mak, Y. Sun, and J. Niu et al. 2022. Processed Food as a Risk Factor for the Development and Perpetuation of Crohn \u2019 s Disease \u2014 The ENIGMA Study. Nutrients 14(17):362.","journal-title":"Nutrients"},{"issue":"6","key":"2561_CR35","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/ecco-jcc\/jjaa254","volume":"15","author":"AS Bancil","year":"2021","unstructured":"Bancil, A. S., A. M. Sandall, M. Rossi, B. Chassaing, and J. O. Lindsay. 2021. W.K. Food Additive Emulsifiers and Their Impact on Gut Microbiome, Permeability, and Inflammation: Mechanistic Insights in Inflammatory Bowel Disease. J Crohns Colitis 15(6):1068.","journal-title":"J Crohns Colitis"},{"issue":"2","key":"2561_CR36","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jcmgh.2018.09.002","volume":"7","author":"F Di Laudisi","year":"2019","unstructured":"Laudisi, F., D. Di Fusco, V. Dinallo, C. Stol, A. Grazia, I. Di, A. Mara, A. Colantoni, C. Ortenzi, Alteri, and F. Guerrieri et al. 2019. The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress-Driven Mucus Depletion and Exacerbates Intestinal Inflammation. Cell Mol Gastroenterol Hepatol 7(2):457\u2013454. https:\/\/doi.org\/10.1016\/j.jcmgh.2018.09.002","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2561_CR37","doi-asserted-by":"publisher","first-page":"101923","DOI":"10.1016\/j.bpg.2024.101923","volume":"72","author":"A Severino","year":"2024","unstructured":"Severino, A., E. Tohumcu, L. Tamai, P. Dargenio, S. Porcari, D. Rondinella, I. Venturini, M. Maida, A. Gasbarrini, and G. Cammarota et al. 2024. The Microbiome-Driven Impact of Western Diet in the Development of Noncommunicable Chronic Disorders. Best Practice & Research Clinical Gastroenterology 72:101923. https:\/\/doi.org\/10.1016\/j.bpg.2024.101923","journal-title":"Best Practice & Research Clinical Gastroenterology"},{"key":"2561_CR38","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41586-022-05308-6","volume":"611","author":"LM Sanmarco","year":"2023","unstructured":"Sanmarco, L. M., C. Chao, Y. Wang, J. E. Kenison, Z. Li, J. M. Rone, C. M. Rejano-gordillo, C. M. Polonio, C. Gutierrez-vazquez, and G. Piester et al. 2023. Identification of Environmental Factors That Promote Intestinal Inflammation. Nature 611:801\u2013809. https:\/\/doi.org\/10.1038\/s41586-022-05308-6","journal-title":"Nature"},{"key":"2561_CR39","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/apt.15774","volume":"51","author":"S Papoutsopoulou","year":"2020","unstructured":"Papoutsopoulou, S., J. Satsangi, B. J. Campbell, and C. S. Probert. 2020. Review Article: Impact of Cigarette Smoking on Intestinal Inflammation\u2014Direct and Indirect Mechanisms. Alimentary Pharmacology & Therapeutics 51:1268\u20131285. https:\/\/doi.org\/10.1111\/apt.15774","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"2561_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/01.mog.0000231808.10773.8e","volume":"22","author":"G Monteleone","year":"2006","unstructured":"Monteleone, G., D. Fina, R. Caruso, and F. Pallone. 2006. New Mediators of Immunity and Inflammation in Inflammatory Bowel Disease. Current Opinion In Gastroenterology 22:361\u2013364. https:\/\/doi.org\/10.1097\/01.mog.0000231808.10773.8e","journal-title":"Current Opinion In Gastroenterology"},{"key":"2561_CR41","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1080\/14712598.2019.1652267","volume":"19","author":"I Marafini","year":"2019","unstructured":"Marafini, I., S. Sedda, V. Dinallo, and G. Monteleone. 2019. Inflammatory Cytokines: From Discoveries to Therapies in IBD. Expert Opinion On Biological Therapy 19:1207\u20131217. https:\/\/doi.org\/10.1080\/14712598.2019.1652267","journal-title":"Expert Opinion On Biological Therapy"},{"key":"2561_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1042\/CS20150132","volume":"129","author":"E Franz\u00e9","year":"2015","unstructured":"Franz\u00e9, E., I. Monteleone, M. L. Cupi, P. Mancia, F. Caprioli, I. Marafini, A. Colantoni, A. Ortenzi, F. Laudisi, and G. Sica et al. 2015. Interleukin-34 Sustains Inflammatory Pathways in the Gut. Clinical Science 129:271\u2013280. https:\/\/doi.org\/10.1042\/CS20150132","journal-title":"Clinical Science"},{"key":"2561_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms26115017","volume":"26","author":"E Tettoni","year":"2025","unstructured":"Tettoni, E., R. Gabbiadini, A. Dal Buono, G. Privitera, V. Vadal\u00e0, G. Migliorisi, P. Bertoli, A. Quadarella, C. Bezzio, and Armuzzi. 2025. A. TL1A as a Target in Inflammatory Bowel Disease: Exploring Mechanisms and Therapeutic Potential. International Journal Of Molecular Sciences 26:1\u201315. https:\/\/doi.org\/10.3390\/ijms26115017","journal-title":"International Journal Of Molecular Sciences"},{"key":"2561_CR44","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1136\/gut.43.6.735","volume":"43","author":"F Pallone","year":"1998","unstructured":"Pallone, F., and G. Monteleone. 1998. Interleukin 12 and Th1 Responses in Inflammatory Bowel Disease. Gut 43:735\u2013736. https:\/\/doi.org\/10.1136\/gut.43.6.735","journal-title":"Gut"},{"key":"2561_CR45","doi-asserted-by":"publisher","unstructured":"Zheng, D., Liwinski, T., and E. Elinav. 2020. Inflammasome activation and regulation: Toward a better understanding of complex mechanisms. Cell Discovery 6:36. https:\/\/doi.org\/10.1038\/s41421-020-0167-x.","DOI":"10.1038\/s41421-020-0167-x"},{"key":"2561_CR46","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.gendis.2022.05.039","volume":"10","author":"W Yang","year":"2023","unstructured":"Yang, W., Y. Wang, T. Wang, C. Li, L. Shi, P. Zhang, Y. Yin, K. Tao, and R. Li. 2023. Protective Effects of IRG1\/Itaconate on Acute Colitis through the Inhibition of Gasdermins-Mediated Pyroptosis and Inflammation Response. Genes Dis 10:1552\u20131563. https:\/\/doi.org\/10.1016\/j.gendis.2022.05.039","journal-title":"Genes Dis"},{"key":"2561_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-04240-3","volume":"12","author":"S Dhani","year":"2021","unstructured":"Dhani, S., Y. Zhao, and B. A. Zhivotovsky. 2021. Long Way to Go: Caspase Inhibitors in Clinical Use. Cell Death And Disease 12:1\u201313. https:\/\/doi.org\/10.1038\/s41419-021-04240-3","journal-title":"Cell Death And Disease"},{"key":"2561_CR48","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3748\/wjg.v29.i6.1026","volume":"29","author":"FEM Ali","year":"2023","unstructured":"Ali, F. E. M., I. M. Ibrahim, O. M. Ghogar, E. K. Abd-Alhameed, H. S. Althagafy, and E. H. M. Hassanein. 2023. Therapeutic Interventions Target the NLRP3 Inflammasome in Ulcerative Colitis: Comprehensive Study. World Journal Of Gastroenterology 29:1026\u20131053. https:\/\/doi.org\/10.3748\/wjg.v29.i6.1026","journal-title":"World Journal Of Gastroenterology"},{"key":"2561_CR49","doi-asserted-by":"publisher","unstructured":"Luu, L. D. W., A. Pandey, S. Paramsothy, C. Ngo, N. Casta\u00f1o-Rodr\u00edguez, C. Liu, M. A. Kamm, T. J. Borody, S. M. Man, and N. O. Kaakoush. 2024. Profiling the Colonic Mucosal Response to Fecal Microbiota Transplantation Identifies a Role for GBP5 in Colitis in Humans and Mice. Nature Communications 15:2645. https:\/\/doi.org\/10.1038\/s41467-024-46983-5.","DOI":"10.1038\/s41467-024-46983-5"},{"key":"2561_CR50","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1007\/s10620-024-08453-2","volume":"69","author":"J Mu","year":"2024","unstructured":"Mu, J., K. Maeda, A. Ohashi, T. Urano, Y. Nariai, H. Kamino, M. Nakamura, T. Yamamura, T. Sawada, and E. Ishikawa et al. 2024. Monoclonal Antibodies Against Mature Interleukin-18 Ameliorate Colitis and Repair Goblet Cell Function. Digestive Diseases And Sciences 69:2573\u20132585. https:\/\/doi.org\/10.1007\/s10620-024-08453-2","journal-title":"Digestive Diseases And Sciences"},{"key":"2561_CR51","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jcmgh.2022.03.003","volume":"14","author":"M De Liso","year":"2022","unstructured":"Liso, M., G. Verna, E. Cavalcanti, S. De Santis, R. Armentano, A. Tafaro, A. Lippolis, P. Campiglia, A. Gasbarrini, and M. Mastronardi et al. 2022. Interleukin 1\u03b2 Blockade Reduces Intestinal Inflammation in a Murine Model of Tumor Necrosis Factor\u2013Independent Ulcerative Colitis. Cmgh 14:151\u2013171. https:\/\/doi.org\/10.1016\/j.jcmgh.2022.03.003","journal-title":"Cmgh"},{"key":"2561_CR52","doi-asserted-by":"publisher","unstructured":"Shaul, E., M. A. Conrad, N. Dawany, T. Patel, M. C. Canavan, A. Baccarella, S. Weinbrom, D. Aleynick, and K. E. Sullivan. 2022. K.J. Canakinumab for the Treatment of Autoinflammatory Very Early Onset- in Fl Ammatory Bowel Disease. Frontiers In Immunology 13(972114). https:\/\/doi.org\/10.3389\/fimmu.2022.972114","DOI":"10.3389\/fimmu.2022.972114"},{"key":"2561_CR53","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/ecco-jcc\/jjab121","volume":"16","author":"V Dinallo","year":"2022","unstructured":"Dinallo, V., D. Di Fusco, A. Di Grazia, F. Laudisi, E. Troncone, G. Di Maggio, E. Franz\u00e8, I. Marafini, A. Colantoni, and A. Ortenzi et al. 2022. The Deubiquitinating Enzyme OTUD5 Sustains Inflammatory Cytokine Response in Inflammatory Bowel Disease. J Crohn\u2019s Colitis 16:122\u2013132. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab121","journal-title":"J Crohn\u2019s Colitis"},{"key":"2561_CR54","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/mi.2014.35","volume":"7","author":"R Caruso","year":"2014","unstructured":"Caruso, R., I. Marafini, E. Franz\u00e8, C. Stolfi, F. Zorzi, I. Monteleone, F. Caprioli, A. Colantoni, M. Sarra, and S. Sedda et al. 2014. Defective Expression of SIRT1 Contributes to Sustain Inflammatory Pathways in the Gut. Mucosal Immunology 7:1467\u20131479. https:\/\/doi.org\/10.1038\/mi.2014.35","journal-title":"Mucosal Immunology"},{"key":"2561_CR55","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1084\/jem.20090847","volume":"206","author":"LM Francisco","year":"2009","unstructured":"Francisco, L. M., V. H. Salinas, K. E. Brown, V. K. Vanguri, G. J. Freeman, V. K. Kuchroo, and A. H. Sharpe. 2009. PD-L1 Regulates the Development, Maintenance, and Function of Induced Regulatory T Cells. Journal Of Experimental Medicine 206:3015\u20133029. https:\/\/doi.org\/10.1084\/jem.20090847","journal-title":"Journal Of Experimental Medicine"},{"key":"2561_CR56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fimmu.2018.01407","volume":"9","author":"E Troncone","year":"2018","unstructured":"Troncone, E., I. Marafini, C. Stolfi, and G. Monteleone. 2018. Transforming Growth Factor-\u03921\/Smad7 in Intestinal Immunity, Inflammation, and Cancer. Frontiers In Immunology 9:4\u20139. https:\/\/doi.org\/10.3389\/fimmu.2018.01407","journal-title":"Frontiers In Immunology"},{"key":"2561_CR57","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1002\/hep.30150","volume":"28","author":"LP Garo","year":"2019","unstructured":"Garo, L. P., A. K. Ajay, M. Fujiwara, V. Beynon, C. Kuhn, G. Gabriely, S. Sadhukan, R. Raheja, S. Rubino, and H. L. Weiner. 2019. Smad7 Controls Immunoregulatory PDL2\/1-PD1 Signaling in Intestinal Inflammation and Autoimmunity. Cell Rep 28:3353\u20133366. https:\/\/doi.org\/10.1002\/hep.30150","journal-title":"Cell Rep"},{"issue":"7","key":"2561_CR58","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/ni805","volume":"3","author":"V Soumelis","year":"2002","unstructured":"Soumelis, V., P. A. Reche, H. Kanzler, W. Yuan, G. Edward, B. Homey, M. Gilliet, S. Ho, S. Antonenko, A. Lauerma, K. Smith, D. Gorman, S. Zurawski, J. Abrams, S. Menon, T. McClanahan, R. de Waal-Malefyt Rd, F. Bazan, and R. A. Kastelein. 2002. Human Epithelial Cells Trigger Dendritic Cell Mediated Allergic Inflammation by Producing TSLP. Nature Immunology 3(7):673\u2013678. https:\/\/doi.org\/10.1038\/ni805","journal-title":"Nature Immunology"},{"issue":"5","key":"2561_CR59","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/ni1192","volume":"6","author":"M Rimoldi","year":"2005","unstructured":"Rimoldi, M., M. Chieppa, V. Salucci, F. Avogadri, A. Sonzogni, G. M. Sampietro, A. Nespoli, G. Viale, and P. Allavena. 2005. Intestinal Immune Homeostasis Is Regulated by the Crosstalk between Epithelial Cells and Dendritic Cells. Nature Immunology 6(5):507\u2013501.","journal-title":"Nature Immunology"},{"key":"2561_CR60","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/B978-0-12-800267-4.00005-5","volume":"122","author":"DS Shouval","year":"2014","unstructured":"Shouval, D. S., D. S. Shouval, J. Ouahed, A. Biswas, J. A. Goettel, B. H. Horwitz, C. Klein, and A. M. Muise. 2014. Interleukin 10 Receptor Signaling: Master Regulator of Intestinal Mucosal Homeostasis in Mice and Humans. Advances In Immunology 122:177\u2013121. https:\/\/doi.org\/10.1016\/B978-0-12-800267-4.00005-5","journal-title":"Advances In Immunology"},{"key":"2561_CR61","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1182\/blood-2008-08-172767","volume":"113","author":"R Caruso","year":"2009","unstructured":"Caruso, R., C. Stolfi, M. Sarra, A. Rizzo, M. C. Fantini, F. Pallone, T. T. MacDonald, and G. Monteleone. 2009. Inhibition of Monocyte-Derived Inflammatory Cytokines by IL-25 Occurs via P38 Map Kinase-Dependent Induction of Socs-3. Blood 113:3512\u20133519. https:\/\/doi.org\/10.1182\/blood-2008-08-172767","journal-title":"Blood"},{"key":"2561_CR62","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1084\/jem.20051496","volume":"203","author":"AM Owyang","year":"2006","unstructured":"Owyang, A. M., C. Zaph, E. H. Wilson, K. J. Guild, T. Mcclanahan, H. R. P. Miller, D. J. Cua, M. Goldschmidt, C. A. Hunter, and R. A. Kastelein et al. 2006. Interleukin 25 Regulates Type 2 Cytokine- Dependent Immunity and Limits Chronic Infl Ammation in the Gastrointestinal Tract. Journal Of Experimental Medicine 203:843\u2013849. https:\/\/doi.org\/10.1084\/jem.20051496","journal-title":"Journal Of Experimental Medicine"},{"issue":"8","key":"2561_CR63","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4049\/jimmunol.0802740","volume":"182","author":"S Ostrand-Rosenberg","year":"2009","unstructured":"Ostrand-Rosenberg, S., and S. P. Myeloid-Derived. 2009. Suppressor Cells: Linking Inflammation and Cancer. The Journal Of Immunology 182(8):449. https:\/\/doi.org\/10.4049\/jimmunol.0802740","journal-title":"The Journal Of Immunology"},{"key":"2561_CR64","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2011.11.011","volume":"36","author":"Jennifer J Ju Qiu","year":"2012","unstructured":"Ju Qiu, Jennifer J., Xiaohuan Heller, Zong-ming E Guo, Kamonwan Chen, and Fish; Yang-Xin Fu. 2012. The Aryl Hydrocarbon Receptor Regulates Gut Immunity through Modulation of Innate Lymphoid Cells. Immunity 36:92\u2013104. https:\/\/doi.org\/10.1016\/j.immuni.2011.11.011","journal-title":"Immunity"},{"key":"2561_CR65","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nri1457","volume":"4","author":"AL Mellor","year":"2004","unstructured":"Mellor, A. L., and D. H. Munn. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nature Reviews Immunology 4:762\u2013774. https:\/\/doi.org\/10.1038\/nri1457","journal-title":"Nature Reviews Immunology"},{"key":"2561_CR66","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","volume":"185","author":"JD Mezrich","year":"2011","unstructured":"Mezrich, J. D., J. H. Fechner, X. Zhang, B. P. Johnson, and J. William. 2011. HYDROCARBON RECEPTOR CAN GENERATE REGULATORY T. The Journal Of Immunology 185:3190\u20133198. https:\/\/doi.org\/10.4049\/jimmunol.0903670","journal-title":"The Journal Of Immunology"},{"key":"2561_CR67","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/cei.13226","volume":"195","author":"A Therrien","year":"2019","unstructured":"Therrien, A., L. Chapuy, M. Bsat, M. Rubio, G. Bernard, E. Arslanian, K. Orlicka, A. Weber, B. P. Panzini, and J. Dorais et al. 2019. Recruitment of Activated Neutrophils Correlates with Disease Severity in Adult Crohn\u2019s Disease. Clinical And Experimental Immunology 195:251\u2013264. https:\/\/doi.org\/10.1111\/cei.13226","journal-title":"Clinical And Experimental Immunology"},{"issue":"e5","key":"2561_CR68","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1016\/j.cgh.2019.12.011","volume":"18","author":"RK Pai","year":"2020","unstructured":"Pai, R. K., D. J. Hartman, C. R. Rivers, M. Regueiro, M. Schwartz, D. G. Binion, and R. K. Pai. 2020. Complete Resolution of Mucosal Neutrophils Associates With Improved Long-Term Clinical Outcomes of Patients With Ulcerative Colitis. Clinical Gastroenterology And Hepatology 18(e5):2510\u20132517. https:\/\/doi.org\/10.1016\/j.cgh.2019.12.011","journal-title":"Clinical Gastroenterology And Hepatology"},{"key":"2561_CR69","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1136\/gutjnl-2015-309598","volume":"65","author":"RV Bryant","year":"2016","unstructured":"Bryant, R. V., D. C. Burger, J. Delo, A. J. Walsh, S. Thomas, A. Von Herbay, O. C. Buchel, L. White, O. Brain, and S. Keshav et al. 2016. Beyond Endoscopic Mucosal Healing in UC: Histological Remission Better Predicts Corticosteroid Use and Hospitalisation over 6 Years of Follow-Up. Gut 65:408\u2013414. https:\/\/doi.org\/10.1136\/gutjnl-2015-309598","journal-title":"Gut"},{"key":"2561_CR70","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/CEG.S51902","volume":"9","author":"NE Walsham","year":"2016","unstructured":"Walsham, N. E., and R. A. Sherwood. 2016. Fecal Calprotectin in Inflammatory Bowel Disease. Clinical And Experimental Gastroenterology 9:21\u201329. https:\/\/doi.org\/10.2147\/CEG.S51902","journal-title":"Clinical And Experimental Gastroenterology"},{"key":"2561_CR71","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2147\/JIR.S497701","volume":"18","author":"T Chen","year":"2025","unstructured":"Chen, T., J. Liu, R. Hang, Q. Chen, D. Wang, and Neutrophils. 2025. From Inflammatory Bowel Disease to Colitis-Associated Colorectal Cancer. J Inflamm Res 18:925\u2013947. https:\/\/doi.org\/10.2147\/JIR.S497701","journal-title":"J Inflamm Res"},{"key":"2561_CR72","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1134\/s0022093021030017","volume":"57","author":"EM Noseykina","year":"2021","unstructured":"Noseykina, E. M., I. A. Schepetkin, and D. N. Atochin. 2021. Molecular Mechanisms for Regulation of Neutrophil Apoptosis under Normal and Pathological Conditions. Journal Of Evolutionary Biochemistry And Physiology 57:429\u2013450. https:\/\/doi.org\/10.1134\/s0022093021030017","journal-title":"Journal Of Evolutionary Biochemistry And Physiology"},{"key":"2561_CR73","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/imr.13163","volume":"314","author":"SD Kobayashi","year":"2023","unstructured":"Kobayashi, S. D., F. R. DeLeo, and M. T. Quinn. 2023. Microbes and the Fate of Neutrophils. Immunological Reviews 314:210\u2013228. https:\/\/doi.org\/10.1111\/imr.13163","journal-title":"Immunological Reviews"},{"key":"2561_CR74","doi-asserted-by":"publisher","first-page":"14983","DOI":"10.1073\/pnas.1206641109","volume":"109","author":"D El Kebira","year":"2012","unstructured":"El Kebira, D., P. Gjorstrup, and J. G. Filepa. 2012. Resolvin E1 Promotes Phagocytosis-Induced Neutrophil Apoptosis and Accelerates Resolution of Pulmonary Inflammation. Proc. Natl. Acad. Sci. U. S. A. 109:14983\u201314988. https:\/\/doi.org\/10.1073\/pnas.1206641109","journal-title":"Proc Natl Acad Sci. U. S. A."},{"key":"2561_CR75","doi-asserted-by":"publisher","unstructured":"Schett, G., and M. F. Neurath. 2018. Resolution of Chronic Inflammatory Disease: Universal and Tissue-Specific Concepts. Nature Communications 9:3261. https:\/\/doi.org\/10.1038\/s41467-018-05800-6.","DOI":"10.1038\/s41467-018-05800-6"},{"issue":"5","key":"2561_CR76","first-page":"233","volume":"194","author":"Mattia Magdalena Herov\u00e1","year":"2015","unstructured":"Magdalena Herov\u00e1, Mattia, Claudio Schmid, and M. H. Gemperle. 2015. ChemR23, the Receptor for Chemerin and Resolvin E1, Is Expressed and Functional on M1 but Not on M2 Macrophages. The Journal Of Immunology 194(5):233.","journal-title":"The Journal Of Immunology"},{"key":"2561_CR77","doi-asserted-by":"publisher","unstructured":"Vermi, W., Riboldi, E., Wittamer, V., Gentili, F., Luini, W., Marrelli, S., Vecchi, A., Franssen, J. D., Communi, D., Massardi, L., Sironi, M., Mantovani, A., Parmentier, M., Facchetti, F., and S. Sozzani. 2005. Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. Journal of Experimental Medicine 201:509\u2013515. https:\/\/doi.org\/10.1084\/jem.20041310.","DOI":"10.1084\/jem.20041310"},{"key":"2561_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciadv.abd1453","volume":"7","author":"C Trilleaud","year":"2021","unstructured":"Trilleaud, C., V. Gauttier, K. Biteau, I. Girault, L. Belarif, C. Mary, S. Pengam, G. Teppaz, V. Thepenier, and R. Danger et al. 2021. Agonist Anti-ChemR23 MAb Reduces Tissue Neutrophil Accumulation and Triggers Chronic Inflammation Resolution. Science Advances 7:1\u201314. https:\/\/doi.org\/10.1126\/sciadv.abd1453","journal-title":"Science Advances"},{"key":"2561_CR79","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.it.2019.05.001","volume":"40","author":"M Phillipson","year":"2019","unstructured":"Phillipson, M., and P. Kubes. 2019. The Healing Power of Neutrophils. Trends In Immunology 40:635\u2013647. https:\/\/doi.org\/10.1016\/j.it.2019.05.001","journal-title":"Trends In Immunology"},{"key":"2561_CR80","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41575-023-00871-3","volume":"21","author":"C Danne","year":"2024","unstructured":"Danne, C., J. Skerniskyte, B. Marteyn, H. Sokol, and Neutrophils. 2024. From IBD to the Gut Microbiota. Nature Reviews. Gastroenterology & Hepatology 21:184\u2013197. https:\/\/doi.org\/10.1038\/s41575-023-00871-3","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"2561_CR81","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jcmgh.2021.03.002","volume":"12","author":"B Drury","year":"2021","unstructured":"Drury, B., G. Hardisty, R. D. Gray, and G. Ho. 2021. tzer Neutrophil Extracellular Traps in Inflammatory Bowel Disease: Pathogenic Mechanisms and Clinical Translation. Cmgh 12:321\u2013333. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.03.002","journal-title":"Cmgh"},{"key":"2561_CR82","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cytogfr.2024.10.003","volume":"80","author":"Y Wu","year":"2024","unstructured":"Wu, Y., and J. Shen. 2024. Unraveling the Intricacies of Neutrophil Extracellular Traps in Inflammatory Bowel Disease: Pathways, Biomarkers, and Promising Therapies. Cytokine & Growth Factor Reviews 80:156\u2013167. https:\/\/doi.org\/10.1016\/j.cytogfr.2024.10.003","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"2561_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00591-7","author":"A Boufenzer","year":"2021","unstructured":"Boufenzer, A., K. Carrasco, L. Jolly, B. Brustolin, E. Di-pillo, M. Derive, and S. Gibot. 2021. Potentiation of NETs Release Is Novel Characteristic of TREM-1 Activation and the Pharmacological Inhibition of TREM-1 Could Prevent from the Deleterious Consequences of NETs Release in Sepsis. Cellular & Molecular Immunology. https:\/\/doi.org\/10.1038\/s41423-020-00591-7","journal-title":"Cellular & Molecular Immunology"},{"key":"2561_CR84","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/ecco-jcc\/jjy215","volume":"13","author":"V Dinallo","year":"2019","unstructured":"Dinallo, V., I. Marafini, D. Di Fusco, F. Laudisi, E. Franz\u00e8, A. Grazia, M. M. Di; Figliuzzi, F. Caprioli, C. Stolfi, and I. Monteleone et al. 2019. Neutrophil Extracellular traps Sustain Inflammatory Signals in Ulcerative Colitis. J Crohn\u2019s Colitis 13:772\u2013784. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy215","journal-title":"J Crohn\u2019s Colitis"},{"key":"2561_CR85","doi-asserted-by":"publisher","unstructured":"Eberl, G., Colonna, M., Di Santo, J. P., and A. N. J. McKenzie. 2015. Innate Lymphoid cells: A new paradigm in immunology. Science 348. https:\/\/doi.org\/10.1126\/science.aaa6566.","DOI":"10.1126\/science.aaa6566"},{"key":"2561_CR86","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature14189","volume":"517","author":"D Artis","year":"2015","unstructured":"Artis, D., and H. Spits. 2015. The Biology of Innate Lymphoid Cells. Nature 517:293\u2013301. https:\/\/doi.org\/10.1038\/nature14189","journal-title":"Nature"},{"key":"2561_CR87","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1146\/annurev-immunol-020711-075053","volume":"30","author":"H Spits","year":"2012","unstructured":"Spits, H., and T. Cupedo. 2012. Innate Lymphoid Cells: Emerging Insights in Development, Lineage Relationships, and Function. Annual Review Of Immunology 30:647\u2013675. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-075053","journal-title":"Annual Review Of Immunology"},{"key":"2561_CR88","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ni.2534","volume":"14","author":"JH Bernink","year":"2013","unstructured":"Bernink, J. H., C. P. Peters, M. Munneke, A. A. Te Velde, S. L. Meijer, K. Weijer, H. S. Hreggvidsdottir, S. E. Heinsbroek, N. Legrand, and C. J. Buskens et al. 2013. Human Type 1 Innate Lymphoid Cells Accumulate in Inflamed Mucosal Tissues. Nature Immunology 14:221\u2013229. https:\/\/doi.org\/10.1038\/ni.2534","journal-title":"Nature Immunology"},{"key":"2561_CR89","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","volume":"38","author":"William Anja Fuchs","year":"2013","unstructured":"Anja Fuchs, William, Jacob S. Vermi, Silvia Lee, Susan Lonardi, R. D. Gilfillan, Marina Newberry, and Cella. 2013. Intraepithelial Type 1 Innate Lymphoid Cells Are a Unique Subset of Cytokine Responsive Interferon-\u03b3-Producing Cells. Immunity 38:769\u2013781. https:\/\/doi.org\/10.1016\/j.immuni.2013.02.010","journal-title":"Immunity"},{"key":"2561_CR90","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/hep.30150","volume":"163","author":"Wendy Teruyuki Sano","year":"2015","unstructured":"Teruyuki Sano, Wendy, Jason A. Huang, Yi Hall, Alessandra Yang, Samuel J. Chen, June-Yong Gavzy, Joshua Lee, Emily R. Ziel, Richard Miraldi, A. Bonneau, and D. R. Littman. 2015. An IL-23R\/IL-22 Circuit Regulates Epithelial Serum Amyloid A to Promote Local Effector Th17 Responses. Cell 163:381\u2013393. https:\/\/doi.org\/10.1002\/hep.30150","journal-title":"Cell"},{"key":"2561_CR91","doi-asserted-by":"publisher","unstructured":"Viladomiu, M., Kivolowitz, C., Abdulhamid, A., Dogan, B., Victorio, D., Castellanos, J. G., Woo, V., Teng, F., Tran, N. L., Sczesnak, A., Chai, C., Kim, M., Diehl, G. E., Ajami, N. J., Petrosino, J. F., Zhou, X. K., Schwartzman, S., Mandl, L. A., Abramowitz, M., Jacob, V., and R. S. Longman et al. 2017. IgA-coated E. coli enriched in Crohn's disease Spondyloarthritis promote TH17-dependent inflammation. Science Translational Medicine 9. https:\/\/doi.org\/10.1126\/scitranslmed.aaf9655.","DOI":"10.1126\/scitranslmed.aaf9655"},{"key":"2561_CR92","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/hep.30150","volume":"51","author":"Sydney Eunyoung Chun","year":"2019","unstructured":"Eunyoung Chun, Sydney, Diogo Lavoie, Sena Fonseca-Pereira, M. M. Bae, R. Hamid, Graeme L. Hoveyda, Carey Ann Gallini Fraser, J. N. Comeau, Miles H. Glickman, Brian T. Fuller, and W. S. G. Layden. 2019. Metabolite-Sensing Receptor Ffar2 Regulates Colonic Group 3 Innate Lymphoid Cells and Gut Immunity. Immunity 51:871\u2013884. https:\/\/doi.org\/10.1002\/hep.30150","journal-title":"Immunity"},{"key":"2561_CR93","doi-asserted-by":"publisher","unstructured":"Marafini, I., Monteleone, I., Laudisi, F., and G. Monteleone. 2024. Aryl hydrocarbon receptor signalling in the control of gut inflammation. International Journal of Molecular Sciences 25:4527. https:\/\/doi.org\/10.3390\/ijms25084527.","DOI":"10.3390\/ijms25084527"},{"key":"2561_CR94","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1126\/science.1214914","volume":"334","author":"EA Kiss","year":"2011","unstructured":"Kiss, E. A., C. Vonarbourg, S. Kopfmann, E. Hobeika, D. Finke, C. Esser, and A. Diefenbach. 2011. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334:1561\u20131565. https:\/\/doi.org\/10.1126\/science.1214914","journal-title":"Science"},{"key":"2561_CR95","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/ni.2187","volume":"13","author":"J Lee","year":"2012","unstructured":"Lee, J., M. Cella, K. Mcdonald, C. Garlanda, G. D. Kennedy, M. Nukaya, A. Mantovani, R. Kopan, and C. A. Bradfield. 2012. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nature Immunology 13:144\u2013151. https:\/\/doi.org\/10.1038\/ni.2187","journal-title":"Nature Immunology"},{"key":"2561_CR96","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/s41418-018-0070-2","volume":"25","author":"Q Hou","year":"2018","unstructured":"Hou, Q., L. Ye, H. Liu, L. Huang, Q. Yang, J. Turner, and Q. Yu. 2018. Lactobacillus Accelerates ISCs Regeneration to Protect the Integrity of Intestinal Mucosa through Activation of STAT3 Signaling Pathway Induced by LPLs Secretion of IL-22. Cell Death And Differentiation 25:1657\u20131670. https:\/\/doi.org\/10.1038\/s41418-018-0070-2","journal-title":"Cell Death And Differentiation"},{"key":"2561_CR97","doi-asserted-by":"publisher","first-page":"115793","DOI":"10.1016\/j.celrep.2025.115793","volume":"44","author":"P Li","year":"2025","unstructured":"Li, P., Y. Zhang, Y. Shen, X. Zhao, R. Mu, and C. Zhong. 2025. ROR\u03b3t Is Crucial for Gut Homeostasis by Regulating the Expression of HB-EGF Rather than IL-22 in Activated ILC3s. Cell Rep 44:115793. https:\/\/doi.org\/10.1016\/j.celrep.2025.115793","journal-title":"Cell Rep"},{"key":"2561_CR98","doi-asserted-by":"publisher","unstructured":"Huang, J., J. Zhang, P. Song, J. Huang, Z. Yang, J. Han, L. Wu, and X. Guo. 2025. P38\u03b1-EIF6-Nsun2 Axis Promotes ILC3\u2019s Rapid Response to Protect Host from Intestinal Inflammation. Journal Of Experimental Medicine 222. https:\/\/doi.org\/10.1084\/jem.20240624","DOI":"10.1084\/jem.20240624"},{"key":"2561_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2024.1402834","volume":"15","author":"X Su","year":"2024","unstructured":"Su, X., L. Zhao, H. Zhang, D. Wang, J. Sun, and L. Shen. 2024. Sirtuin 6 Inhibits Group 3 Innate Lymphoid Cell Function and Gut Immunity by Suppressing IL-22 Production. Frontiers In Immunology 15:1\u201312. https:\/\/doi.org\/10.3389\/fimmu.2024.1402834","journal-title":"Frontiers In Immunology"},{"key":"2561_CR100","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.mucimm.2025.02.005","volume":"18","author":"J Li","year":"2025","unstructured":"Li, J., J. Jacobse, J. M. Pilat, H. Kaur, W. Gu, S. W. Kang, M. Rusznak, H. Huang, J. Barrera, and P. A. Oloo et al. 2025. Interleukin-10 production by innate lymphoid cells restricts intestinal inflammation in mice. Mucosal Immunology 18:643\u2013655. https:\/\/doi.org\/10.1016\/j.mucimm.2025.02.005","journal-title":"Mucosal Immunology"},{"key":"2561_CR101","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41423-024-01246-7","volume":"22","author":"Y Wang","year":"2025","unstructured":"Wang, Y., J. Wang, G. Liu, X. Yi, J. Wu, H. Cao, L. Zhang, P. Zhou, Y. Fan, and Y. Yu et al. 2025. NRP1 Instructs IL-17-Producing ILC3s to Drive Colitis Progression. Cellular & Molecular Immunology 22:161\u2013175. https:\/\/doi.org\/10.1038\/s41423-024-01246-7","journal-title":"Cellular & Molecular Immunology"},{"key":"2561_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI174198","volume":"134","author":"S Cao","year":"2024","unstructured":"Cao, S., J. L. Fachi, K. Ma, A. U. Antonova, Q. Wang, Z. Cai, R. J. Kaufman, M. A. Ciorba, P. Deepak, and M. Colonna. 2024. The IRE1\u03b1\/XBP1 Pathway Sustains Cytokine Responses of Group 3 Innate Lymphoid Cells in Inflammatory Bowel Disease. J Clin Invest 134:1\u201316. https:\/\/doi.org\/10.1172\/JCI174198","journal-title":"J Clin Invest"},{"key":"2561_CR103","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1053\/j.gastro.2004.12.042","volume":"128","author":"G Monteleone","year":"2005","unstructured":"Monteleone, G., I. Monteleone, D. Fina, P. Vavassori, G. Del Vecchio Blanco, R. Caruso, R. Tersigni, L. Alessandroni, L. Biancone, and G. C. Naccari et al. 2005. Interleukin-21 Enhances T-Helper Cell Type I Signaling and Interferon-\u03b3 Production in Crohn\u2019s Disease. Gastroenterology 128:687\u2013694. https:\/\/doi.org\/10.1053\/j.gastro.2004.12.042","journal-title":"Gastroenterology"},{"key":"2561_CR104","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0016-5085(99)70177-0","volume":"116","author":"M Boirivant","year":"1999","unstructured":"Boirivant, M., M. Marini, G. Di Felice, A. M. Pronio, C. Montesani, R. Tersigni, and W. Strober. 1999. Lamina Propria T Cells in Crohn\u2019s Disease and Other Gastrointestinal Inflammation Show Defective CD2 Pathway-Induced Apoptosis. Gastroenterology 116:557\u2013565. https:\/\/doi.org\/10.1016\/S0016-5085(99)70177-0","journal-title":"Gastroenterology"},{"key":"2561_CR105","doi-asserted-by":"publisher","first-page":"7234","DOI":"10.4049\/jimmunol.165.12.7234","volume":"165","author":"T Parrello","year":"2000","unstructured":"Parrello, T., G. Monteleone, S. Cucchiara, I. Monteleone, L. Sebkova, P. Doldo, F. Luzza, and F. Pallone. 2000. Up-Regulation of the IL-12 Receptor \u03922 Chain in Crohn\u2019s Disease. The Journal Of Immunology 165:7234\u20137239. https:\/\/doi.org\/10.4049\/jimmunol.165.12.7234","journal-title":"The Journal Of Immunology"},{"key":"2561_CR106","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000437106","volume":"33","author":"I Marafini","year":"2015","unstructured":"Marafini, I., E. Angelucci, F. Pallone, and G. Monteleone. 2015. The IL-12\/23\/STAT Axis as a Therapeutic Target in Inflammatory Bowel Disease: Mechanisms and Evidence in Man. Digestive Diseases 33:113\u2013119. https:\/\/doi.org\/10.1159\/000437106","journal-title":"Digestive Diseases"},{"key":"2561_CR107","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1053\/j.gastro.2025.03.035","volume":"169","author":"P Menghini","year":"2025","unstructured":"Menghini, P., L. F. Butt\u00f3, A. Gomez-Nguyen, N. Aladyshkina, K. A. Buela, A. Osme, R. Chan, H. L. Wargo, S. De Santis, and G. Bamias et al. 2025. Tumor Necrosis Factor-Like Ligand 1A\/Death Receptor 3 Signaling Regulates the Generation of Pathogenic T Helper 9 Cells in Experimental Crohn\u2019s Disease. Gastroenterology 169:892\u2013908. https:\/\/doi.org\/10.1053\/j.gastro.2025.03.035","journal-title":"Gastroenterology"},{"key":"2561_CR108","doi-asserted-by":"publisher","unstructured":"Monteleone, I., F. Pallone, and G. Monteleone. 2011. Th17-Related Cytokines: New Players in the Control of Chronic Intestinal Inflammation. Bmc Medicine 9:122. https:\/\/doi.org\/10.1186\/1741-7015-9-122.","DOI":"10.1186\/1741-7015-9-122"},{"key":"2561_CR109","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.it.2008.02.008","volume":"29","author":"G Monteleone","year":"2008","unstructured":"Monteleone, G., F. Pallone, and T. T. MacDonald. 2008. Interleukin-21: A Critical Regulator of the Balance between Effector and Regulatory T-Cell Responses. Trends In Immunology 29:290\u2013294. https:\/\/doi.org\/10.1016\/j.it.2008.02.008","journal-title":"Trends In Immunology"},{"key":"2561_CR110","doi-asserted-by":"publisher","first-page":"113570","DOI":"10.1016\/j.intimp.2024.113570","volume":"143","author":"J Wang","year":"2024","unstructured":"Wang, J., Y. Hou, L. Mu, M. Yang, and X. Ai. 2024. Gut Microbiota Contributes to the Intestinal and Extraintestinal Immune Homeostasis by Balancing Th17\/Treg Cells. International Immunopharmacology 143:113570. https:\/\/doi.org\/10.1016\/j.intimp.2024.113570","journal-title":"International Immunopharmacology"},{"key":"2561_CR111","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cell.2019.11.026","volume":"180","author":"JY Lee","year":"2020","unstructured":"Lee, J. Y., J. A. Hall, L. Kroehling, L. Wu, T. Najar, H. H. Nguyen, W. Y. Lin, S. T. Yeung, H. M. Silva, and D. Li et al. 2020. Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease. Cell 180:79\u201391e16. https:\/\/doi.org\/10.1016\/j.cell.2019.11.026","journal-title":"Cell"},{"key":"2561_CR112","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"139","author":"II Ivanov","year":"2010","unstructured":"Ivanov, I. I., K. Atarashi, N. Manel, E. L. Brodie, U. Karaoz, D. Wei, K. C. Goldfarb, C. A. Santee, V. Lynch, and T. Tanoue et al. 2010. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485\u2013498. https:\/\/doi.org\/10.1016\/j.cell.2009.09.033","journal-title":"Cell"},{"key":"2561_CR113","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1172\/JCI95376","volume":"127","author":"N Colliou","year":"2017","unstructured":"Colliou, N., Y. Ge, B. Sahay, M. Gong, M. Zadeh, J. L. Owen, J. Neu, W. G. Farmerie, F. Alonzo, and K. Liu et al. 2017. Commensal Propionibacterium Strain UF1 Mitigates Intestinal Inflammation via Th17 Cell Regulation. J Clin Invest 127:3970\u20133986. https:\/\/doi.org\/10.1172\/JCI95376","journal-title":"J Clin Invest"},{"key":"2561_CR114","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1021\/acs.jafc.9b07987","volume":"68","author":"Q Ren","year":"2020","unstructured":"Ren, Q., Y. J. Tang, L. Zhang, Y. Xu, N. Liu, and H. Ren. 2020. Exopolysaccharide Produced by Lactobacillus Casei Promotes the Differentiation of CD4\u2009+\u2009T Cells into Th17 Cells in BALB\/c Mouse Peyer\u2019s Patches in Vivo and in Vitro. Journal Of Agriculture And Food Chemistry 68:2664\u20132672. https:\/\/doi.org\/10.1021\/acs.jafc.9b07987","journal-title":"Journal Of Agriculture And Food Chemistry"},{"key":"2561_CR115","doi-asserted-by":"publisher","unstructured":"Huang, Y., Tang, J., Cai, Z., Zhou, K., Chang, L., Bai, Y., and Y. Ma. 2020. Prevotella induces the production of Th17 cells in the colon of mice. Mediators of Inflammation 2020:9607328. https:\/\/doi.org\/10.1155\/2020\/9607328.","DOI":"10.1155\/2020\/9607328"},{"issue":"1","key":"2561_CR116","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1038\/s41467-022-31229-z","volume":"13","author":"A Globig","year":"2022","unstructured":"Globig, A., A. V. Hipp, M. Heeg, V. Tomov, R. Thimme, P. Hasselblatt, B. Bengsch, L. S. Mayer, S. Ehl, and H. Schwacha et al. 2022. High-Dimensional pro Fi Ling Reveals Tc17 Cell Enrichment in Active Crohn \u2019 s Disease and Identi Fi Es a Potentially Targetable Signature. Nature Communications 13(1):3688. https:\/\/doi.org\/10.1038\/s41467-022-31229-z","journal-title":"Nature Communications"},{"key":"2561_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/sji.13332","volume":"98","author":"K Chen","year":"2023","unstructured":"Chen, K., X. Gu, S. Yang, R. Tao, M. Fan, W. Bao, and X. Wang. 2023. Research Progress on Intestinal Tissue-Resident Memory T Cells in Inflammatory Bowel Disease. Scandinavian Journal Of Immunology 98:1\u201318. https:\/\/doi.org\/10.1111\/sji.13332","journal-title":"Scandinavian Journal Of Immunology"},{"key":"2561_CR118","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/intimm\/dxae043","volume":"37","author":"L Ge","year":"2025","unstructured":"Ge, L., M. Xu, M. Huang, S. Liu, Z. Zhou, Z. Xia, S. Dong, Q. Zhao, R. Zhu, and F. Zhou. 2025. The Canonical Hippo Pathway Components Modulate the Differentiation of Lamina Propria Regulatory T Cells and T Helper 17-like Regulatory T Cells in Mouse Colitis. International Immunology 37:25\u201338. https:\/\/doi.org\/10.1093\/intimm\/dxae043","journal-title":"International Immunology"},{"key":"2561_CR119","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1053\/j.gastro.2019.01.025","volume":"156","author":"R Goldberg","year":"2019","unstructured":"Goldberg, R., C. Scotta, D. Cooper, E. Nissim-Eliraz, E. Nir, S. Tasker, P. M. Irving, J. Sanderson, P. Lavender, and F. Ibrahim et al. 2019. Correction of Defective T-Regulatory Cells From Patients With Crohn\u2019s Disease by Ex Vivo Ligation of Retinoic Acid Receptor-\u03b1. Gastroenterology 156:1775\u20131787. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.025","journal-title":"Gastroenterology"},{"key":"2561_CR120","first-page":"37","volume":"78","author":"KC Wu","year":"1989","unstructured":"Wu, K. C., Y. R. Mahida, J. D. Priddle, D. P. J. G. Unit, and R. Infirmary. 1989. Immunoglobulin Production by Isolated Intestinal Mononuclear Cells from Patients with Ulcerative Colitis and Crohn \u2019 s Disease. Clin exp Immunol 78:37\u201341.","journal-title":"Clin exp Immunol"},{"issue":"6","key":"2561_CR121","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1177\/10668969231152242","volume":"31","author":"D Escobar","year":"2023","unstructured":"Escobar, D., O. Bushara, L. Sun, and J. Liao. 2023. High-Density IgG4\u2009+\u2009Plasma Cells Infiltration Is Associated With Fibroplasia in Fibrostenotic Crohn\u2019s Disease. International Journal Of Surgical Pathology 31(6):1085\u20131092.","journal-title":"International Journal Of Surgical Pathology"},{"key":"2561_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.157013","volume":"7","author":"S Zhang","year":"2022","unstructured":"Zhang, S., X. Morgan, B. Dogan, F. P. Martin, S. Strickler, A. Oka, J. Herzog, B. Liu, S. E. Dowd, and C. Huttenhower et al. 2022. Mucosal Metabolites Fuel the Growth and Virulence of E. Coli Linked to Crohn\u2019s Disease. JCI Insight 7:1\u201320. https:\/\/doi.org\/10.1172\/jci.insight.157013","journal-title":"JCI Insight"},{"key":"2561_CR123","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1172\/jci20295","volume":"113","author":"MJ Lodes","year":"2004","unstructured":"Lodes, M. J., Y. Cong, C. O. Elson, R. Mohamath, C. J. Landers, S. R. Targan, M. Fort, and R. M. Hershberg. 2004. Bacterial Flagellin Is a Dominant Antigen in Crohn Disease. J Clin Invest 113:1296\u20131306. https:\/\/doi.org\/10.1172\/jci20295","journal-title":"J Clin Invest"},{"key":"2561_CR124","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1365-2249.2003.02392.x","volume":"135","author":"LJ Walker","year":"2004","unstructured":"Walker, L. J., M. C. Aldhous, H. E. Drummond, B. R. K. Smith, E. R. Nimmo, I. D. R. Arnott, J. Satsangi, and Anti-Saccharomyces. 2004. Cerevisiae Antibodies (ASCA) in Crohn\u2019s Disease Are Associated with Disease Severity but Not NOD2\/CARD15 Mutations. Clinical And Experimental Immunology 135:490\u2013496. https:\/\/doi.org\/10.1111\/j.1365-2249.2003.02392.x","journal-title":"Clinical And Experimental Immunology"},{"key":"2561_CR125","doi-asserted-by":"publisher","unstructured":"McNamee, E. N., and J. Rivera-Nieves. 2016. Ectopic tertiary lymphoid tissue in inflammatory bowel disease: protective or provocateur? Frontiers In Immunology 7:308. https:\/\/doi.org\/10.3389\/fimmu.2016.00308.","DOI":"10.3389\/fimmu.2016.00308"},{"key":"2561_CR126","doi-asserted-by":"crossref","unstructured":"Nagase, Y., S. Okano, A. Furukawa, T. Kanazawa, K. Yamamoto, K. Yamamoto, K. Ohashi, T. Yamana, S. Nojiri, and Y. Suzuki et al. 2024. Tertiary Lymphoid Structure as a Therapeutic Target of Crohn\u2019s Disease: Modulation by TNF\u03b1 Blockade. bioRxiv 2024.11.23.625032.","DOI":"10.1101\/2024.11.23.625032"},{"key":"2561_CR127","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000521259","volume":"89","author":"O Bushara","year":"2022","unstructured":"Bushara, O., D. J. Escobar, S. E. Weinberg, L. Sun, J. Liao, and G. Y. Yang. 2022. The Possible Pathogenic Role of IgG4-Producing Plasmablasts in Stricturing Crohn\u2019s Disease. Pathobiology 89:187\u2013197. https:\/\/doi.org\/10.1159\/000521259","journal-title":"Pathobiology"},{"key":"2561_CR128","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cytogfr.2009.02.002","volume":"20","author":"G Monteleone","year":"2009","unstructured":"Monteleone, G., F. Pallone, and T. T. Macdonald. 2009. Interleukin-21 (IL-21)-Mediated Pathways in T Cell-Mediated Disease. Cytokine & Growth Factor Reviews 20:185\u2013191. https:\/\/doi.org\/10.1016\/j.cytogfr.2009.02.002","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"2561_CR129","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/S0016-5085(99)70391-4","volume":"117","author":"G Monteleone","year":"1999","unstructured":"Monteleone, G., T. T. MacDonald, N. C. Wathen, F. Pallone, and S. L. F. Pender. 1999. Enhancing Lamina Propria Th1 Cell Responses with Interleukin 12 Produces Severe Tissue Injury. Gastroenterology 117:1069\u20131077. https:\/\/doi.org\/10.1016\/S0016-5085(99)70391-4","journal-title":"Gastroenterology"},{"key":"2561_CR130","doi-asserted-by":"publisher","unstructured":"Biancheri, P., S. L. F. Pender, F. Ammoscato, P. Giuffrida, G. Sampietro, S. Ardizzone, A. Ghanbari, R. Curciarello, A. Pasini, and G. Monteleone et al. 2013. The Role of Interleukin 17 in Crohn\u2019s Disease-Associated Intestinal Fibrosis. Fibrogenes Tissue Repair 6:13. https:\/\/doi.org\/10.1186\/1755-1536-6-13.","DOI":"10.1186\/1755-1536-6-13"},{"key":"2561_CR131","doi-asserted-by":"publisher","unstructured":"Diez-Martin, E., L. Hernandez-Suarez, C. Mu\u00f1oz-Villafranca, L. Martin-Souto, E. Astigarraga, A. Ramirez-Garcia, and G. Barreda-G\u00f3mez. 2024. Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options. International Journal Of Molecular Sciences 25:7062. https:\/\/doi.org\/10.3390\/ijms25137062.","DOI":"10.3390\/ijms25137062"},{"key":"2561_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-023-40156-6","volume":"14","author":"A Garrido-Trigo","year":"2023","unstructured":"Garrido-Trigo, A., A. M. Corraliza, M. Veny, I. Dotti, E. Mel\u00f3n-Ardanaz, A. Rill, H. L. Crowell, \u00c1. Corb\u00ed, V. Gudi\u00f1o, and M. Esteller et al. 2023. Macrophage and Neutrophil Heterogeneity at Single-Cell Spatial Resolution in Human Inflammatory Bowel Disease. Nature Communications 14:1\u201318. https:\/\/doi.org\/10.1038\/s41467-023-40156-6","journal-title":"Nature Communications"},{"key":"2561_CR133","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41588-025-02225-y","volume":"57","author":"L Kong","year":"2025","unstructured":"Kong, L., S. Subramanian, \u00c5. Segerstolpe, V. Tran, A. R. Shih, G. T. Carter, H. Kunitake, S. W. Twardus, J. Li, and S. Gandhi et al. 2025. Single-Cell and Spatial Transcriptomics of Stricturing Crohn\u2019s Disease Highlights a Fibrosis-Associated Network. Nature Genetics 57:1742\u20131753. https:\/\/doi.org\/10.1038\/s41588-025-02225-y","journal-title":"Nature Genetics"},{"key":"2561_CR134","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3748\/wjg.v20.i5.1165","volume":"14","author":"G Mike","year":"2008","unstructured":"Mike, G., Porfirio Laukoetter, and A. N. Nava. 2008. Intestinal Barrier in Inflammatory Bowel Disease. World Journal Of Gastroenterology 14:401\u2013407. https:\/\/doi.org\/10.3748\/wjg.v20.i5.1165","journal-title":"World Journal Of Gastroenterology"},{"key":"2561_CR135","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.crohns.2014.02.009","volume":"8","author":"Z Kerami","year":"2014","unstructured":"Kerami, Z., N. W. Duijvis, E. W. Vogels, F. H. van Dooren, P. D. Moerland, and A. A. Te Velde. 2014. Effect of Interleukin-17 on Gene Expression Profile of Fibroblasts from Crohn\u2019s Disease Patients. J Crohn\u2019s Colitis 8:1208\u20131216. https:\/\/doi.org\/10.1016\/j.crohns.2014.02.009","journal-title":"J Crohn\u2019s Colitis"},{"key":"2561_CR136","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri3661","volume":"14","author":"MF Neurath","year":"2014","unstructured":"Neurath, M. F. 2014. Cytokines in Inflammatory Bowel Disease. Nature Reviews Immunology 14:329\u2013342. https:\/\/doi.org\/10.1038\/nri3661","journal-title":"Nature Reviews Immunology"},{"key":"2561_CR137","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.matbio.2025.05.001","volume":"139","author":"SN Lin","year":"2025","unstructured":"Lin, S. N., J. Wang, P. K. Mukherjee, I. Veisman, W. J. Massey, R. Mao, J. Chandra, C. Fiocchi, and F. Rieder. 2025. The Functional Role of the Extracellular Matrix in Inflammatory Bowel Disease Associated Gut Fibrosis. Matrix Biology 139:29\u201348. https:\/\/doi.org\/10.1016\/j.matbio.2025.05.001","journal-title":"Matrix Biology"},{"key":"2561_CR138","doi-asserted-by":"publisher","first-page":"6536","DOI":"10.1016\/j.cell.2025.08.029","volume":"188","author":"KE Bauer-Rowe","year":"2025","unstructured":"Bauer-Rowe, K. E., B. Pham, M. Griffin, N. E. Liang, A. Kim, J. M. Lu, M. Januszyk, J. L. Guo, S. De Santis, Y. Xing, A. Prystupa, I. Sidhu, E. J. Suh, D. S. Foster, M. Korah, A. Goyal, D. C. Wan, J. A. Norton, D. Delitto, T. T. Pizarro, S. L. Naik, and J. S. Hyun. 2025. Creeping Fat-Derived Mechanosensitive Fibroblasts Drive Intestinal Fibrosis in Crohn\u2019s Disease Strictures. Cell 188:6536\u20136553ko.","journal-title":"Cell"},{"key":"2561_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/https","volume":"18","author":"Xiaomin Jinyu Tan","year":"2025","unstructured":"Jinyu Tan, Xiaomin, Weidong Wu, Jinshen Huang*, J. N. He, Zishan Longyuan Zhou, Yu Liu, Caiguang Wang, Jie Liu, Y. Z. Li, and R. M. Minhu Chen. 2025. Fibroblast-Derived Interleukin-11 as a Potential Biomarker for Intestinal Fibrostenosis in Crohn\u2019s Disease. Ther Adv Gastroenterol 18:1\u201316. https:\/\/doi.org\/10.1177\/https","journal-title":"Ther Adv Gastroenterol"},{"key":"2561_CR140","doi-asserted-by":"publisher","unstructured":"Levantovsky, R. M., Tastad, C., Zhang, J., Gettler, K., Sabic, K., Werner, R., Chasteau, C., Korie, U., Paguay, D., Bao, M., Han, H., Maskey, N., Talware, S., Patel, M., Argmann, C., Suarez-Farinas, M., Harpaz, N., Chuang, L. S., and J. H. Cho. 2024. Multimodal single-cell analyses reveal mechanisms of perianal fistula in diverse patients with Crohn\u2019s disease. Med 5:886\u2013908.e11. https:\/\/doi.org\/10.1016\/j.medj.2024.03.021.","DOI":"10.1016\/j.medj.2024.03.021"},{"key":"2561_CR141","doi-asserted-by":"publisher","unstructured":"McGregor, C., Qin, X., Jagielowicz, M., Gupta, T., Yin, Z., Lentsch, V., Fawkner-Corbett, D., Lai, V. W., Castro, P. G., Bridges, E., Lee, C. H. J., Chuang, H. W., Deng, L., Aulicino, A., Teague, R., Moradi, S., Park, J. S., Woo, J., Xu, K., Tandon, R., Cianci, N., Bornschein, J., Ho, L. P., Siejka-Zielinska, P., et al. 2026. Spatial fibroblast niches define Crohn\u2019s Fistulae. Nature 649:703\u2013712. https:\/\/doi.org\/10.1038\/s41586-025-09744-y","DOI":"10.1038\/s41586-025-09744-y"},{"key":"2561_CR142","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-336246","author":"V Gudi\u00f1o","year":"2025","unstructured":"Gudi\u00f1o, V., J.-W. Cho, B. Caballol, A. M. Corraliza, M. Veny, I. Dotti, L. M. Genaro, \u00c1. Sanzo-Machuca, E. Mel\u00f3n-Ardanaz, and M. C. Masamunt et al. 2025. TL1A-Activated T Cells Remodel the Rectal Mucosa in Crohn\u2019s Disease Patients with Perianal Fistulizing Disease. Gut. https:\/\/doi.org\/10.1136\/gutjnl-2025-336246","journal-title":"Gut"},{"issue":"1","key":"2561_CR143","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/gutjnl-2018-316023","volume":"68","author":"S Zeissig","year":"2019","unstructured":"Zeissig, S., E. Rosati, C. M. Dowds, K. Aden, J. Bethge, B. Schulte, W. H. Pan, N. Mishra, M. Zuhayra, M. Marx, M. Paulsen, A. Strigli, C. Conrad, D. Schuldt, A. Sinha, H. Ebsen, S. C. Kornell, S. Nikolaus, A. Arlt, D. Kabelitz, M. Ellrichmann, U. L\u00fctzen, P. C. Rosenstiel, and A. Franke. 2019. Vedolizumab Is Associated with Changes in Innate Rather than Adaptive Immunity in Patients with Inflammatory Bowel Disease. Gut 68(1):25\u201323.","journal-title":"Gut"},{"issue":"9","key":"2561_CR144","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1136\/gutjnl-2023-331696","volume":"73","author":"RY Van Der Gabri\u00ebls","year":"2024","unstructured":"Gabri\u00ebls, R. Y., A. M. Waaij, M. D. Van Der Linssen, M. Dobosz, P. Volkmer, S. Jalal, D. Robinson, D. Hooge, Festen, and E. A. M. Hermoso et al. 2024. M.A.;. Fluorescently Labelled Vedolizumab to Visualise Drug Distribution and Mucosal Target Cells in Inflammatory Bowel Disease. Gut 73(9):1454. https:\/\/doi.org\/10.1136\/gutjnl-2023-331696","journal-title":"Gut"},{"key":"2561_CR145","doi-asserted-by":"publisher","first-page":"103410","DOI":"10.1016\/j.autrev.2023.103410","volume":"22","author":"G Monteleone","year":"2023","unstructured":"Monteleone, G., A. Moscardelli, A. Colella, I. Marafini, and S. Salvatori. 2023. Immune-Mediated Inflammatory Diseases: Common and Different Pathogenic and Clinical Features. Autoimmun Rev 22:103410. https:\/\/doi.org\/10.1016\/j.autrev.2023.103410","journal-title":"Autoimmun Rev"},{"key":"2561_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjae121","volume":"19","author":"G Dragoni","year":"2025","unstructured":"Dragoni, G., B. J. Ke, L. Picariello, S. Abdurahiman, E. Ceni, F. Biscu, T. Mello, S. Polvani, T. Innocenti, and V. Spalart et al. 2025. The Impact of Peptidyl Arginine Deiminase 4-Dependent Neutrophil Extracellular Trap Formation on the Early Development of Intestinal Fibrosis in Crohn\u2019s Disease. J Crohn\u2019s Colitis 19:1\u201312. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjae121","journal-title":"J Crohn\u2019s Colitis"},{"key":"2561_CR147","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3969\/j.issn.1000-8179.20130819","volume":"40","author":"H Wu","year":"2013","unstructured":"Wu, H., and Q. Hao. 2013. Research Progress in Molecular Targeted Therapy for Gynecological Cancer. Chinese J Clin Oncol 40:1341\u20131343. https:\/\/doi.org\/10.3969\/j.issn.1000-8179.20130819","journal-title":"Chinese J Clin Oncol"},{"issue":"1","key":"2561_CR148","doi-asserted-by":"publisher","first-page":"G58","DOI":"10.1100\/tsw.2011.139","volume":"329","author":"SA Samant","year":"2025","unstructured":"Samant, S. A., S. K. Hyoju, and J. C. Alverdy, G.M. 2025. The Multifaceted Role of Sirtuins in Inflammatory Bowel Diseases. American Journal Of Physiology. Gastrointestinal And Liver Physiology 329(1):G58\u2013G68. https:\/\/doi.org\/10.1100\/tsw.2011.139","journal-title":"American Journal Of Physiology. Gastrointestinal And Liver Physiology"},{"key":"2561_CR149","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3904\/kjim.2024.019","volume":"39","author":"EM Song","year":"2024","unstructured":"Song, E. M., Y. H. Joo, S. A. Jung, J. R. Byeon, A. R. Choe, Y. Park, C. H. Tae, C. M. Moon, S. E. Kim, and H. K. Jung et al. 2024. The Role of PD-1\/PD-L1 Pathway in Ulcerative Colitis and Changes Following Tonsil-Derived Mesenchymal Stem Cells Treatment. Korean Journal Of Internal Medicine 39:917\u2013930. https:\/\/doi.org\/10.3904\/kjim.2024.019","journal-title":"Korean Journal Of Internal Medicine"},{"key":"2561_CR150","doi-asserted-by":"publisher","unstructured":"Haupt, J., Keminer, O., Neser, C., Windsh\u00fcgel, B., Wiltzsch, V., Schmidt, J. R., Pliushcheuskaya, P., K\u00fcnze, G., Scholz, U., M\u00fcller, C., Oliveira da Rocha, G. H., Biermann, M. K., Zdzieblo, D., Metzger, M., Schiefke, I., Neurath, M. F., Siegmund, B., Claussen, C., K\u00f6hl, U., Geisslinger, G., et al. 2025. Novel Aryl Hydrocarbon receptor agonists as potential anti-inflammatory therapeutics: Identification and validation through drug repurposing. Biochemical Pharmacology 240:117066. https:\/\/doi.org\/10.1016\/j.bcp.2025.117066.","DOI":"10.1016\/j.bcp.2025.117066"},{"key":"2561_CR151","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1053\/j.gastro.2023.03.230","volume":"165","author":"JR Allegretti","year":"2023","unstructured":"Allegretti, J. R., V. Mitsialis, J. B. Canavan, M. Hamilton, J. Barends, M. Carrellas, K. Freer, J. Gringauz, J. Green, and N. Herwood et al. 2023. Low-Dose Interleukin 2 for the Treatment of Moderate to Severe Ulcerative Colitis. Gastroenterology 165:492\u2013495e2. https:\/\/doi.org\/10.1053\/j.gastro.2023.03.230","journal-title":"Gastroenterology"},{"key":"2561_CR152","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/mt.2011.290","volume":"20","author":"G Monteleone","year":"2012","unstructured":"Monteleone, G., M. C. Fantini, S. Onali, F. Zorzi, G. Sancesario, S. Bernardini, E. Calabrese, F. Viti, I. Monteleone, and L. Biancone et al. 2012. Phase I Clinical Trial of Smad7 Knockdown Using Antisense Oligonucleotide in Patients with Active Crohn\u2019s Disease. Molecular Therapy 20:870\u2013876. https:\/\/doi.org\/10.1038\/mt.2011.290","journal-title":"Molecular Therapy"},{"key":"2561_CR153","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1056\/nejmoa1407250","volume":"372","author":"G Monteleone","year":"2015","unstructured":"Monteleone, G., M. F. Neurath, S. Ardizzone, A. Di Sabatino, M. C. Fantini, F. Castiglione, M. L. Scribano, A. Armuzzi, F. Caprioli, and G. C. Sturniolo et al. 2015. Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn\u2019s Disease. New England Journal Of Medicine 372:1104\u20131113. https:\/\/doi.org\/10.1056\/nejmoa1407250","journal-title":"New England Journal Of Medicine"},{"key":"2561_CR154","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/apt.12051","volume":"36","author":"F Zorzi","year":"2012","unstructured":"Zorzi, F., E. Calabrese, I. Monteleone, M. Fantini, S. Onali, L. Biancone, F. Pallone, and G. A. Monteleone. 2012. Phase 1 Open-Label Trial Shows That Smad7 Antisense Oligonucleotide (GED0301) Does Not Increase the Risk of Small Bowel Strictures in Crohn\u2019s Disease. Alimentary Pharmacology & Therapeutics 36:850\u2013857. https:\/\/doi.org\/10.1111\/apt.12051","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"2561_CR155","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/apt.13526","volume":"43","author":"G Monteleone","year":"2016","unstructured":"Monteleone, G., A. Di Sabatino, S. Ardizzone, F. Pallone, K. Usiskin, X. Zhan, G. Rossiter, and M. F. Neurath. 2016. Impact of Patient Characteristics on the Clinical Efficacy of Mongersen (GED-0301), an Oral Smad7 Antisense Oligonucleotide, in Active Crohn\u2019s Disease. Alimentary Pharmacology & Therapeutics 43:717\u2013724. https:\/\/doi.org\/10.1111\/apt.13526","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"2561_CR156","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s40259-021-00482-x","volume":"35","author":"I Di Marafini","year":"2021","unstructured":"Marafini, I., C. Stolfi, E. Troncone, E. Lolli, S. Onali, O. A. Paoluzi, M. C. Fantini, L. Biancone, E. Calabrese, and A. Di Grazia et al. 2021. A Pharmacological Batch of Mongersen That Downregulates Smad7 Is Effective as Induction Therapy in Active Crohn\u2019s Disease: A Phase II, Open-Label Study. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals And Gene Therapy 35:325\u2013336. https:\/\/doi.org\/10.1007\/s40259-021-00482-x","journal-title":"Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals And Gene Therapy"},{"key":"2561_CR157","doi-asserted-by":"publisher","first-page":"738","DOI":"10.14309\/ajg.0000000000000493","volume":"115","author":"BE Sands","year":"2020","unstructured":"Sands, B. E., B. G. Feagan, W. J. Sandborn, S. Schreiber, L. Peyrin-Biroulet, J. F. Colombel, G. Rossiter, K. Usiskin, S. Ather, and X. Zhan et al. 2020. Mongersen (GED-0301) for Active Crohn\u2019s Disease: Results of a Phase 3 Study. American Journal Of Gastroenterology 115:738\u2013745. https:\/\/doi.org\/10.14309\/ajg.0000000000000493","journal-title":"American Journal Of Gastroenterology"},{"key":"2561_CR158","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1089\/nat.2021.0089","volume":"32","author":"L Arrico","year":"2022","unstructured":"Arrico, L., C. Stolfi, I. Marafini, G. Monteleone, S. Demartis, S. Bellinvia, F. Viti, M. Mcnulty, I. Cabani, and A. Falezza et al. 2022. Inhomogeneous Diastereomeric Composition of Mongersen Antisense Phosphorothioate Oligonucleotide Preparations and Related Pharmacological Activity Impairment. Nucleic Acid Ther 32:312\u2013320. https:\/\/doi.org\/10.1089\/nat.2021.0089","journal-title":"Nucleic Acid Ther"},{"key":"2561_CR159","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/ecco-jcc\/jjz012","volume":"13","author":"C Deutschmann","year":"2019","unstructured":"Deutschmann, C., M. Sowa, J. Murugaiyan, U. Roesler, N. R\u00f6ber, K. Conrad, M. W. Laass, D. Bogdanos, N. Sipeki, and M. Papp et al. 2019. Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn\u2019s Disease. J Crohn\u2019s Colitis 13:894\u2013904. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz012","journal-title":"J Crohn\u2019s Colitis"},{"key":"2561_CR160","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI179472","volume":"134","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y., J. Wang, H. Sun, Z. Xun, Z. He, Y. Zhao, J. Qi, S. Sun, Q. Yang, and Y. Gu et al. 2024. TWIST1\u2009+\u2009FAP+ Fibroblasts in the Pathogenesis of Intestinal Fibrosis in Crohn\u2019s Disease. J Clin Invest 134:1\u201316. https:\/\/doi.org\/10.1172\/JCI179472","journal-title":"J Clin Invest"},{"key":"2561_CR161","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1136\/gutjnl-2023-329963","volume":"73","author":"F Rieder","year":"2024","unstructured":"Rieder, F., P. K. Mukherjee, W. J. Massey, Y. Wang, and C. Fiocchi. 2024. Fibrosis in IBD: From Pathogenesis to Therapeutic Targets. Gut 73:854\u2013866. https:\/\/doi.org\/10.1136\/gutjnl-2023-329963","journal-title":"Gut"},{"issue":"9","key":"2561_CR162","doi-asserted-by":"publisher","first-page":"jjaf137","DOI":"10.1093\/ecco-jcc\/jjaf137","volume":"19","author":"D de Nikolakis","year":"2025","unstructured":"Nikolakis, D., A. Y. F. Li Yim, K. L. Overberg, M. Ghiboub, M. E. Wildenberg, W. J. de Jonge, D. Lartey, F. Rieder, G. R. D\u2019Haens, and M. G. H. van de Sande. 2025. L.M. Drug Repurposing Approach for the Discovery of Therapeutic Agents for Crohn\u2019s Disease-Associated Intestinal Fibrosis. J Crohns Colitis 19(9):jjaf137.","journal-title":"J Crohns Colitis"},{"key":"2561_CR163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.00583","volume":"10","author":"V Valatas","year":"2019","unstructured":"Valatas, V., G. Kolios, and G. Bamias. 2019. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-Stimulatory System of Cytokines with Diverse Functions in Gut Mucosal Immunity. Frontiers In Immunology 10:1\u201314. https:\/\/doi.org\/10.3389\/fimmu.2019.00583","journal-title":"Frontiers In Immunology"},{"key":"2561_CR164","doi-asserted-by":"crossref","unstructured":"Feagan, B. G., Sands, B. E., Siegel, C. A., Dubinsky, M. C., Longman, R. S., Sabino, J., Laurent, O., Luo, A., Lu, J., Nguyen, D. D., Mu\u00f1oz-Elias, E. J., Llewellyn, H., Wang, Y., Jang, I., Bilsborough, J., Marchelletta, R., Towfic, F., Yen, M., Anderson, J. K., DuVall, A., Kierkus, J., Woynarowski, M., and M. D. Al Kharrat. 2025. Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn\u2019s disease: A phase 2a induction trial. Lancet Gastroenterology & Hepatology 10(8):e10.","DOI":"10.1016\/S2468-1253(25)00071-8"},{"key":"2561_CR165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-10769-x","volume":"10","author":"P Czarnewski","year":"2019","unstructured":"Jacob, N., Jacobs, P. J., Kumagai, K., Ha, C. W. Y., Kanazawa, Y., Lagishetty, V., Altmayer, K., Hamill, A. M., Von Arx, A., Sartor, R. B., Devkota, S., Braun, J., Michelsen, K. S., and S. R. Targan S.D. 2018. Inflammation independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiome. Mucosal Immunology 11(5):1466\u20131476. https:\/\/doi.org\/10.1053\/j.gastro.2019.03.013.","journal-title":"Nature Communications"},{"key":"2561_CR166","doi-asserted-by":"publisher","unstructured":"Zorzi, F., Monteleone, I., Sarra, M., Calabrese, E., Marafini, I., Cretella, M., Sedda, S., Biancone, L., Pallone, F., and G. Monteleone. 2013. Distinct profiles of effector cytokines mark the different phases of Crohn\u2019s disease. PLoS ONE 8. https:\/\/doi.org\/10.1371\/journal.pone.0054562.","DOI":"10.1371\/journal.pone.0054562"},{"key":"2561_CR167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2021.653924","volume":"12","author":"I Marafini","year":"2021","unstructured":"Czarnewski, P., Parigi, S. M., Sorini, C., Diaz, O. E., Das, S., Gagliani, N., and E. J. Villablanca. 2019. Conserved transcriptomic profile between mouse and human colitis allows unsupervised patient stratification. Nature Communications 10:1\u201311. https:\/\/doi.org\/10.1038\/s41467-019-10769-x.","journal-title":"Frontiers In Pharmacology"},{"key":"2561_CR168","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41575-019-0228-5","volume":"17","author":"JL Digby-Bell","year":"2020","unstructured":"Marafini, I., Salvatori, S., Troncone, E., and G. Monteleone. 2025. CD19 CAR T-cell therapy for refractory ulcerative colitis. Gastroenterology 118\u2013120. https:\/\/doi.org\/10.1053\/j.gastro.2025.11.013.","journal-title":"Nature Reviews. Gastroenterology &amp; Hepatology"},{"issue":"8","key":"2561_CR169","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1016\/S2468-1253(25)00071-8","volume":"10","author":"BG Feagan","year":"2025","unstructured":"Marafini, I., and G. Monteleone. 2021. Precision medicine in inflammatory bowel diseases. Frontiers in Pharmacology 12:1\u20136. https:\/\/doi.org\/10.3389\/fphar.2021.653924.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"2561_CR170","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1053\/j.gastro.2019.03.013.Mechanical","volume":"11","author":"N Von Jacob","year":"2018","unstructured":"Digby-Bell, J. L., Atreya, R., Monteleone, G., and N. Powell. 2020. Interrogating host immunity to predict treatment response in inflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology 17:9\u201320. https:\/\/doi.org\/10.1038\/s41575-019-0228-5.","journal-title":"Mucosal Immunology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02561-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02561-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02561-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:35:51Z","timestamp":1791250551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-026-02561-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":170,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2561"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02561-z","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Giovanni Monteleone served as a consultant for First Wave BioPharma and Giuliani SpA and as a speaker for Takeda, Eli Lilly, Abbvie, Galapagos, and Pfizer and filed a patent related to the treatment of inflammatory bowel diseases with Smad7 antisense oligonu-cleotides. Irene Marafini served as a consultant and speaker for Abbvie, Eli Lilly and Galapagos.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"195"}}